Advanced biologics and patient-specific therapies reduce opportunities for terminal sterilization, elevating proactive microbial risk control and integrating QC microbiology into CCS authorship, risk ...

Joshua Hare, MD, FACC, FAHA, Co-Founder, Chief Science Officer and Executive Chairman, Longeveron · GlobeNewswire Inc. MIAMI, April 08, 2026 (GLOBE NEWSWIRE)-- Longeveron Inc. (NASDAQ: LGVN), a ...

Potency assay development uses DoE and QbD to improve accuracy, consistency, and regulatory readiness in biologics testing.

A consistent upward trend has been seen in extrapulmonary tuberculosis cases in the past five years, constituting nearly 24% ...

Safety and efficacy are the two regulatory benchmarks for pharmaceutical products. Microbial contamination of products is an important aspect of product quality that can affect both safety and ...

Even when bacteria appear susceptible in routine tests, tolerance can let them survive therapy long enough to drive ...

Microbiology is the study of microscopic organisms, such as bacteria, viruses, archaea, fungi and protozoa. This discipline includes fundamental research on the biochemistry, physiology, cell biology, ...

Objective: To evaluate the detection performance of microfluidic chip-based multiplex PCR technology for rapid detection of ...

EM, researchers showed that water mediates catalysis and important protein interactions for RNA polymerase II function in ...

Consolidating adverse event databases is a smart move, but without public education, real-time transparency risks becoming ...

Recently disclosed microscopic imaging techniques are helping to better describe how disease processes unfold and how potential therapies might intervene. Innovative technologies are improving spatial ...

Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...